Company overview
Basic information
Company name
Delta biosciences, UAB
Company code
305656641
VAT code
LT100013912913
Registered address
Kaunas, Sukilėlių pr. 45, LT-50140
Registration date
2020-11-13
Company age: 5 y. 11 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Other research and experimental development on natural sciences and engineering
Ownership form
Private without foreign capital
UAB "Delta biosciences"
Company code: 305656641
Address: Kaunas, Sukilėlių pr. 45, LT-50140
VAT code: LT100013912913
Description
This description was generated by artificial intelligence.
Delta biosciences, UAB (company code 305656641) is an operational private limited liability company registered in 2020. It is a private company in the national private non-financial companies sector, under private ownership, with Lithuanian natural and legal persons holding more than 50% of the authorised capital and no foreign investor capital. Governance is limited to a CEO. The company is based in Kaunas, at Sukileliu pr. 45, Kauno m. sav., Kauno apskr. Its main activity is coded N.72.10.90: Research and experimental development on other natural sciences and engineering.
In 2025, Delta biosciences generated EUR 102.4K in revenue, up 28.1% year on year, and reported net profit of EUR 1.4K with a profit margin of 1.4%. Equity remained negative at EUR 97.3K, while liabilities stood at EUR 166.4K and total assets at EUR 69.1K. The company’s share capital is EUR 5.0K.
The workforce averaged 8 employees so far in 2026, after 9 in 2025 and 6 in both 2023 and 2024. The average monthly wage was EUR 629.27 so far in 2026, compared with EUR 1,018.65 in 2025 and EUR 1,008.16 in 2024. Estimated annual payroll is EUR 60.4K.
In 2025, Delta biosciences generated EUR 102.4K in revenue, up 28.1% year on year, and reported net profit of EUR 1.4K with a profit margin of 1.4%. Equity remained negative at EUR 97.3K, while liabilities stood at EUR 166.4K and total assets at EUR 69.1K. The company’s share capital is EUR 5.0K.
The workforce averaged 8 employees so far in 2026, after 9 in 2025 and 6 in both 2023 and 2024. The average monthly wage was EUR 629.27 so far in 2026, compared with EUR 1,018.65 in 2025 and EUR 1,008.16 in 2024. Estimated annual payroll is EUR 60.4K.
Download a detailed company report
Make confident decisions with all the information about Delta biosciences, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.